Overview
Jinho Park practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, Lung Nodules, and Non-Small Cell Lung Cancer (NSCLC).
They are actively involved in clinical research, co-authoring 19 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jinho Park
Is Jinho Park a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Jinho Park is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jinho Park participate in research or clinical trials?
Yes. Jinho Park has published 19 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Jinho Park's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaPark isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerPark isExperienced. Learn about Lung Cancer.
- Lung NodulesPark isExperienced. Learn about Lung Nodules.
- Non-Small Cell Lung Cancer (NSCLC)